<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01670487</url>
  </required_header>
  <id_info>
    <org_study_id>GEB-02</org_study_id>
    <nct_id>NCT01670487</nct_id>
  </id_info>
  <brief_title>Vapocoolant (Pain Ease Medium Stream) for Intravenous Lines in Emergency Department Patients</brief_title>
  <official_title>Prospective,Randomized,Blinded, Comparative,Efficacy and Safety Trial of Vapocoolant (Pain Ease Medium Stream) for Intravenous Cannulation in Emergency Department Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Gebauer Company</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the efficacy and safety of vapocoolant stream (Pain Ease Medium Stream ) in
      decreasing the pain of intravenous cannulation.

      To compare vapocoolant stream (Pain Ease medium Stream) with control (e.g. sterile water)
      stream.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Vapocoolant sprays have been used to decrease the pain associated with painful medical
      procedures such as immunizations, needle aspirations, injections, venipuncture and
      intravenous cannulation. In general, vapocoolant sprays , have been found to be effective in
      decreasing the pain of various medical procedures. Moreover, the use of vapocoolant sprays
      ,unlike other local anesthetics , such as infiltrative lidocaine , is not associated with a
      painful injection and does affect the success rate of the procedure including intravenous
      cannulation and may even increase the success rate of the intravenous cannulation.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain Score on the Numeric Rating Scale (NRS)</measure>
    <time_frame>pain of intravenous catheter placement.</time_frame>
    <description>Numeric rating scale (NRS) 0-10 : 0 (no pain) - 5 (moderate pain) - 10 (worst pain). Scores to be utilized after stream device applied and after intravenous catheter placement.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">300</enrollment>
  <condition>Pain</condition>
  <arm_group>
    <arm_group_label>Vapocoolant (Pain Ease Medium Stream)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Application of the stream steadily 4 to 10 seconds onto the cannulation site.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Nature's Tears</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Apply sterile water (see manufacturer above) steadily 4-10 seconds onto the cannulation site.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vapocoolant</intervention_name>
    <description>Topical stream of 4 to 10 seconds duration to skin</description>
    <arm_group_label>Vapocoolant (Pain Ease Medium Stream)</arm_group_label>
    <other_name>Pain Ease stream</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sterile water</intervention_name>
    <description>Topical intervention of sterile water stream 4 to 10 seconds to skin.</description>
    <arm_group_label>Nature's Tears</arm_group_label>
    <other_name>Nature's Tears by Bio-Logic Aqua Technologies</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients needing intravenous cannulation

          -  Adults age 18 years equal or greater than.

          -  Stable patient

          -  Mentally competent patient able to understand the consent form

        Exclusion Criteria:

          -  Patients with any allergies to the spray components ( e.g.1,1,3,3, pentafluoropropane
             or 1,1,1,2 tetrafluoroethane )

          -  Critically ill or unstable patient (e.g. sepsis or shock)

          -  Infants and children of age , &lt;18 years.

          -  Pregnant

          -  Intravenous cannulation site located in area of compromised blood supply. (ex:
             patients with Peripheral Vascular Disease , Raynaud's disease, gangrene, Buerger's
             disease)

          -  Intravenous cannulation site located in area of insensitive skin; such as , patients
             with a peripheral neuropathy including diabetic neuropathy.

          -  Patient intolerant of cold or with hypersensitivity to the cold.

          -  Patient unable or unwilling to give consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sharon E. Mace, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Cleveland Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Cleveland Clinic</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Hijazi R, Taylor D, Richardson J. Effect of topical alkane vapocoolant spray on pain with intravenous cannulation in patients in emergency departments: randomised double blind placebo controlled trial. BMJ. 2009 Feb 10;338:b215. doi: 10.1136/bmj.b215.</citation>
    <PMID>19208703</PMID>
  </reference>
  <reference>
    <citation>Page DE, Taylor DM. Vapocoolant spray vs subcutaneous lidocaine injection for reducing the pain of intravenous cannulation: a randomized, controlled, clinical trial. Br J Anaesth. 2010 Oct;105(4):519-25. doi: 10.1093/bja/aeq198. Epub 2010 Aug 3.</citation>
    <PMID>20682573</PMID>
  </reference>
  <reference>
    <citation>Biro P, Meier T, Cummins AS. Comparison of topical anaesthesia methods for venous cannulation in adults. Eur J Pain. 1997;1(1):37-42.</citation>
    <PMID>15102427</PMID>
  </reference>
  <reference>
    <citation>Hartstein BH, Barry JD. Mitigation of pain during intravenous catheter placement using a topical skin coolant in the emergency department. Emerg Med J. 2008 May;25(5):257-61. doi: 10.1136/emj.2006.044776.</citation>
    <PMID>18434455</PMID>
  </reference>
  <reference>
    <citation>Baxter AL, Leong T, Mathew B. External thermomechanical stimulation versus vapocoolant for adult venipuncture pain: pilot data on a novel device. Clin J Pain. 2009 Oct;25(8):705-10. doi: 10.1097/AJP.0b013e3181af1236.</citation>
    <PMID>19920721</PMID>
  </reference>
  <reference>
    <citation>Patterson P, Hussa AA, Fedele KA, Vegh GL, Hackman CM. Comparison of 4 analgesic agents for venipuncture. AANA J. 2000 Feb;68(1):43-51.</citation>
    <PMID>10876451</PMID>
  </reference>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 13, 2012</study_first_submitted>
  <study_first_submitted_qc>August 20, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 22, 2012</study_first_posted>
  <results_first_submitted>February 1, 2016</results_first_submitted>
  <results_first_submitted_qc>July 29, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 21, 2016</results_first_posted>
  <last_update_submitted>July 29, 2016</last_update_submitted>
  <last_update_submitted_qc>July 29, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Sharon Mace</investigator_full_name>
    <investigator_title>Staff Physician &amp; Research Director, Emergency Services Institute</investigator_title>
  </responsible_party>
  <keyword>Vapocoolant</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Camphor</mesh_term>
    <mesh_term>Menthol</mesh_term>
    <mesh_term>Salicylates</mesh_term>
    <mesh_term>Methyl salicylate</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Vapocoolant (Pain Ease Medium Stream)</title>
          <description>Application of the stream steadily 4 to 10 seconds onto the cannulation site.
Vapocoolant: Topical stream of 4 to 10 seconds duration to skin</description>
        </group>
        <group group_id="P2">
          <title>Nature's Tears</title>
          <description>Apply sterile water (see manufacturer above) steadily 4-10 seconds onto the cannulation site.
Sterile water: Topical intervention of sterile water stream 4 to 10 seconds to skin.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="150"/>
                <participants group_id="P2" count="150"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="150"/>
                <participants group_id="P2" count="150"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>adults undergoing IV annulation in ED</population>
      <group_list>
        <group group_id="B1">
          <title>Vapocoolant (Pain Ease Medium Stream)</title>
          <description>Applied Vapoccolant in a topical stream of 4 to 10 seconds duration to skin</description>
        </group>
        <group group_id="B2">
          <title>Nature's Tears</title>
          <description>Applied Nature's Tears in a topical stream of 4 to 10 seconds duration to skin</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="150"/>
            <count group_id="B2" value="150"/>
            <count group_id="B3" value="300"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52" lower_limit="35" upper_limit="60"/>
                    <measurement group_id="B2" value="50" lower_limit="37" upper_limit="62"/>
                    <measurement group_id="B3" value="51" lower_limit="35" upper_limit="62"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="94"/>
                    <measurement group_id="B2" value="64"/>
                    <measurement group_id="B3" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56"/>
                    <measurement group_id="B2" value="86"/>
                    <measurement group_id="B3" value="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Pain Score on the Numeric Rating Scale (NRS)</title>
        <description>Numeric rating scale (NRS) 0-10 : 0 (no pain) - 5 (moderate pain) - 10 (worst pain). Scores to be utilized after stream device applied and after intravenous catheter placement.</description>
        <time_frame>pain of intravenous catheter placement.</time_frame>
        <population>adults undergoing placement of an intravenous line in the emergency department</population>
        <group_list>
          <group group_id="O1">
            <title>Vapocoolant (Pain Ease Medium Stream)</title>
            <description>Application of the stream steadily 4 to 10 seconds onto the cannulation site.
Vapocoolant: Topical stream of 4 to 10 seconds duration to skin</description>
          </group>
          <group group_id="O2">
            <title>Placebo (Nature's Tears)</title>
            <description>Application of the stream steadily for 4 to 10 seconds</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score on the Numeric Rating Scale (NRS)</title>
          <description>Numeric rating scale (NRS) 0-10 : 0 (no pain) - 5 (moderate pain) - 10 (worst pain). Scores to be utilized after stream device applied and after intravenous catheter placement.</description>
          <population>adults undergoing placement of an intravenous line in the emergency department</population>
          <units>NRS</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="150"/>
                <count group_id="O2" value="150"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.3" spread="2.4"/>
                    <measurement group_id="O2" value="4.3" spread="3.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Vapocoolant (Pain Ease Medium Stream)</title>
          <description>Application of the stream steadily 4 to 10 seconds onto the cannulation site.
Vapocoolant: Topical stream of 4 to 10 seconds duration to skin</description>
        </group>
        <group group_id="E2">
          <title>Nature's Tears</title>
          <description>Apply sterile water (see manufacturer above) steadily 4-10 seconds onto the cannulation site.
Sterile water: Topical intervention of sterile water stream 4 to 10 seconds to skin.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="150"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>skin irritation such as redness or blanching</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="150"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="150"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Sharon Mace</name_or_title>
      <organization>Cleveland Clinic</organization>
      <phone>216-445-4598</phone>
      <email>maces@ccf.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

